Cortexin Reference
Educational, not medical advice reference for Cortexin: Cognitive, Longevity; regulatory status, evidence posture, source review, and schedule n…
Plain English
- What it is
- Cortexin is a mix of small brain proteins, called peptides, made from the cerebral cortex (the outer layer of the brain) of cattle. It is sold as a prescription medicine in Russia and several nearby countries, but it is not approved by the US Food and Drug Administration (FDA).
- What people use it for
- In Russia and nearby countries, doctors give it after strokes, head injuries, and other brain conditions, and in children with learning or development delays. Online, people also talk about it for brain fog, memory, and recovery after a concussion.
- What the science shows
- Most of the studies come from Russia, and many are done in animals rather than people. When reviewers looked for solid human studies, they found very few, and the ones they found had quality problems, so the hoped-for brain benefits are not proven by strong research.
- The catch
- It is not FDA-approved, and the research outside Russia is limited and debated. It is made from cow brain tissue, the way another country regulates it is not US medical guidance, and there is no proven long-term brain-boosting effect.
Reference summary
Russian-language randomized trial literature exists, primarily in stroke, TBI, and pediatric cognitive disorders. Publication quality and generalizability outside Russia / CIS regulatory frameworks are debated.
Regulatory and posture
- Categories
- Cognitive, Longevity
- Aliases
- Bovine cortical neuropeptide preparation
- Evidence posture
- translational - Approved in Russia / CIS but not FDA-approved. Trial quality and generalizability outside the Russian regulatory framework are debated. No validated Western community protocol exists.
- Regulatory status
- No FDA-approved Cortexin drug label. Cortexin is a low-molecular-weight neuropeptide preparation derived from bovine cerebral cortex, approved in the Russian Federation and several CIS countries for stroke, traumatic brain injury, encephalopathy, and learning / memory indications. It is not FDA-approved.
- Content review status
- research reference
Selected public sources
Related tools
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.
For research and educational purposes only. Not medical advice.